Discontinued — last reported Q1 '18
Otis Worldwide Allowance for Doubtful Accounts Receivable (Current) remained flat by 0.0% to $125.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $119.00M to $125.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows a downward trend with a -4.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $170.00M | $177.00M | $175.00M | $188.00M | $166.00M | $156.00M | $152.00M | $139.00M | $143.00M | $126.00M | $130.00M | $133.00M | $131.00M | $132.00M | $125.00M | $119.00M | $121.00M | $126.00M | $125.00M | $125.00M |
| QoQ Change | — | +4.1% | -1.1% | +7.4% | -11.7% | -6.0% | -2.6% | -8.6% | +2.9% | -11.9% | +3.2% | +2.3% | -1.5% | +0.8% | -5.3% | -4.8% | +1.7% | +4.1% | -0.8% | +0.0% |
| YoY Change | — | — | — | — | -2.4% | -11.9% | -13.1% | -26.1% | -13.9% | -19.2% | -14.5% | -4.3% | -8.4% | +4.8% | -3.8% | -10.5% | -7.6% | -4.5% | +0.0% | +5.0% |